{"filing":{"accession_number":"0001035267-26-000047","cik":"0001035267","ticker":"ISRG","company_name":"INTUITIVE SURGICAL INC","form":"8-K","filing_date":"2026-07-16","report_date":null,"primary_document":"isrg-20260716.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000047/isrg-20260716.htm"},"events":[{"id":18394,"run_id":16535,"accession_number":"0001035267-26-000047","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"summary":"Item 2.02 discloses Intuitive Surgical's Q2 2026 financial results via press release dated July 16, 2026. The filing reports quarterly revenue of $2.89 billion (19% growth), GAAP net income of $818 million ($2.29 per diluted share), and non-GAAP net income of $1.00 billion ($2.80 per diluted share), along with operational metrics including 16% procedure growth and 468 da Vinci system placements. This is a standard quarterly earnings release material to investors.","company_name":"INTUITIVE SURGICAL INC","ticker":"ISRG","filing_date":"2026-07-16","form":"8-K","submitted_at":null,"items":[{"id":17190,"accession_number":"0001035267-26-000047","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"Item 2.02 discloses Intuitive Surgical's Q2 2026 financial results via press release dated July 16, 2026. The filing reports quarterly revenue of $2.89 billion (19% growth), GAAP net income of $818 million ($2.29 per diluted share), and non-GAAP net income of $1.00 billion ($2.80 per diluted share), along with operational metrics including 16% procedure growth and 468 da Vinci system placements. This is a standard quarterly earnings release material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:06:57.031104+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17190,"accession_number":"0001035267-26-000047","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"Item 2.02 discloses Intuitive Surgical's Q2 2026 financial results via press release dated July 16, 2026. The filing reports quarterly revenue of $2.89 billion (19% growth), GAAP net income of $818 million ($2.29 per diluted share), and non-GAAP net income of $1.00 billion ($2.80 per diluted share), along with operational metrics including 16% procedure growth and 468 da Vinci system placements. This is a standard quarterly earnings release material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:06:57.031104+00:00","company_name":"INTUITIVE SURGICAL INC","ticker":"ISRG","filing_date":"2026-07-16"}]}